ASX - By Stock
|
PDI |
Re:
Ann: Excellent Results from Argo Central Trend
|
|
Damolition
|
8 |
2.7K |
4 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
8
|
2.7K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
Damolition
|
154 |
45K |
1 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
45K
|
1
|
|
Charts
|
PDI |
Re:
PDI Chart and T/A
|
|
Damolition
|
1.2K |
389K |
3 |
14/03/24 |
14/03/24 |
Charts
|
1.2K
|
389K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Damolition
|
532 |
194K |
3 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
532
|
194K
|
3
|
|
ASX - By Stock
|
XTC |
Re:
Ann: Quarterly Activities Report Dec 2023
|
|
Damolition
|
27 |
10K |
4 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
27
|
10K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Damolition
|
9.4K |
2.7M |
3 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
9.4K
|
2.7M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change of Director's Interest Notice - Silviu Itescu
|
|
Damolition
|
185 |
45K |
2 |
24/12/23 |
24/12/23 |
ASX - By Stock
|
185
|
45K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Annual Report to Shareholders
|
|
Damolition
|
74 |
24K |
3 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
74
|
24K
|
3
|
|
ASX - By Stock
|
XTC |
Re:
Ann: Response to ASX accounts query
|
|
Damolition
|
32 |
13K |
5 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
32
|
13K
|
5
|
|
Charts
|
PDI |
Re:
PDI Chart and T/A
|
|
Damolition
|
1.2K |
389K |
3 |
20/09/23 |
20/09/23 |
Charts
|
1.2K
|
389K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Damolition
|
17K |
6.6M |
0 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
17K
|
6.6M
|
0
|
|
ASX - By Stock
|
QAN |
Re:
$24 million for walking out the door after earning over 100 million.
|
|
Damolition
|
45 |
11K |
2 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
45
|
11K
|
2
|
|
ASX - By Stock
|
QAN |
Re:
Ann: Announcement on Qantas CEO Succession
|
|
Damolition
|
96 |
20K |
3 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
96
|
20K
|
3
|
|
ASX - By Stock
|
QAN |
Re:
$24 million for walking out the door after earning over 100 million.
|
|
Damolition
|
45 |
11K |
3 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
45
|
11K
|
3
|
|
ASX - By Stock
|
QAN |
Re:
$24 million for walking out the door after earning over 100 million.
|
|
Damolition
|
45 |
11K |
2 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
45
|
11K
|
2
|
|
ASX - By Stock
|
XTC |
Re:
XTC General discussion
|
|
Damolition
|
2.5K |
1.0M |
4 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
4
|
|
ASX - By Stock
|
QAN |
Re:
$24 million for walking out the door after earning over 100 million.
|
|
Damolition
|
45 |
11K |
5 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
45
|
11K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Damolition
|
1.0K |
388K |
5 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Damolition
|
1.0K |
388K |
1 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Damolition
|
3.4K |
1.1M |
2 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
2
|
|
ASX - By Stock
|
PDI |
Re:
Ann: Response to ASX Price Query
|
|
Damolition
|
24 |
9.0K |
2 |
20/06/23 |
20/06/23 |
ASX - By Stock
|
24
|
9.0K
|
2
|
|
ASX - By Stock
|
PDI |
Re:
Ann: Response to ASX Price Query
|
|
Damolition
|
24 |
9.0K |
8 |
19/06/23 |
19/06/23 |
ASX - By Stock
|
24
|
9.0K
|
8
|
|
ASX - By Stock
|
XTC |
Re:
XTC General discussion
|
|
Damolition
|
2.5K |
1.0M |
6 |
15/06/23 |
15/06/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
6
|
|
ASX - By Stock
|
PDI |
Re:
Ann: Trading Halt
|
|
Damolition
|
36 |
13K |
4 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
36
|
13K
|
4
|
|
ASX - By Stock
|
XTC |
Re:
XTC General discussion
|
|
Damolition
|
2.5K |
1.0M |
2 |
01/06/23 |
01/06/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
2
|
|
ASX - By Stock
|
PDI |
Re:
Ann: Trading Halt
|
|
Damolition
|
73 |
19K |
3 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
73
|
19K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Reports Q3 Financial Results and Operational Highlights
|
|
Damolition
|
362 |
112K |
1 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
362
|
112K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Damolition
|
3.4K |
1.1M |
1 |
15/04/23 |
15/04/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
1
|
|
ASX - By Stock
|
KDY |
Re:
Ann: Request for Extension of Voluntary Suspension
|
|
Damolition
|
54 |
14K |
1 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
54
|
14K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change in substantial holding
|
|
Damolition
|
12 |
3.5K |
0 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
12
|
3.5K
|
0
|
|
ASX - By Stock
|
XTC |
Re:
XTC General discussion
|
|
Damolition
|
2.5K |
1.0M |
7 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
2.5K
|
1.0M
|
7
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change in substantial holding
|
|
Damolition
|
12 |
3.5K |
2 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
12
|
3.5K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Damolition
|
1.0K |
382K |
0 |
11/03/23 |
11/03/23 |
ASX - By Stock
|
1.0K
|
382K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Damolition
|
1.0K |
382K |
1 |
11/03/23 |
11/03/23 |
ASX - By Stock
|
1.0K
|
382K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Damolition
|
1.0K |
382K |
4 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
1.0K
|
382K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Despatch of Retail Offer Booklet
|
|
Damolition
|
25 |
7.9K |
1 |
06/03/23 |
06/03/23 |
ASX - By Stock
|
25
|
7.9K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Despatch of Retail Offer Booklet
|
|
Damolition
|
25 |
7.9K |
0 |
06/03/23 |
06/03/23 |
ASX - By Stock
|
25
|
7.9K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Despatch of Retail Offer Booklet
|
|
Damolition
|
25 |
7.9K |
1 |
22/02/23 |
22/02/23 |
ASX - By Stock
|
25
|
7.9K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Despatch of Retail Offer Booklet
|
|
Damolition
|
25 |
7.9K |
0 |
22/02/23 |
22/02/23 |
ASX - By Stock
|
25
|
7.9K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
Damolition
|
9 |
2.9K |
0 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
9
|
2.9K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
Damolition
|
9 |
2.9K |
0 |
20/02/23 |
20/02/23 |
ASX - By Stock
|
9
|
2.9K
|
0
|
|
ASX - By Stock
|
PDI |
Re:
Ann: Outstanding Infill Drilling Results Continue
|
|
Damolition
|
416 |
67K |
4 |
12/02/23 |
12/02/23 |
ASX - By Stock
|
416
|
67K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
CHF - MSB's Dark Horse with Multi-billion dollar potential
|
|
Damolition
|
516 |
154K |
1 |
10/02/23 |
10/02/23 |
ASX - By Stock
|
516
|
154K
|
1
|
|
ASX - By Stock
|
XTC |
Re:
an explanation please
|
|
Damolition
|
67 |
24K |
9 |
10/02/23 |
10/02/23 |
ASX - By Stock
|
67
|
24K
|
9
|
|
ASX - By Stock
|
XTC |
Re:
an explanation please
|
|
Damolition
|
67 |
24K |
1 |
08/02/23 |
08/02/23 |
ASX - By Stock
|
67
|
24K
|
1
|
|
ASX - By Stock
|
XTC |
Re:
Ann: Drilling to Commence on Lithium Targets at Southern Cross
|
|
Damolition
|
21 |
7.5K |
4 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
21
|
7.5K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
Damolition
|
914 |
285K |
1 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
914
|
285K
|
1
|
|
ASX - By Stock
|
KDY |
Re:
10-15 Cents by March 2023
|
|
Damolition
|
219 |
79K |
2 |
19/01/23 |
19/01/23 |
ASX - By Stock
|
219
|
79K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
I'd Suggest MSB is Undervalued
|
|
Damolition
|
10 |
2.7K |
2 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
10
|
2.7K
|
2
|
|
ASX - By Stock
|
XTC |
Re:
Ann: Xantippe to Raise up to $20 Million in Placement & SPP
|
|
Damolition
|
89 |
31K |
1 |
07/12/22 |
07/12/22 |
ASX - By Stock
|
89
|
31K
|
1
|
|